Olaris is a precision medicine company that produces personalized "Biomarkers of Response" (BoR) to differentiate drug responders and drug non-responders.
Company (Alive / Active)
35 Gatehouse Dr.
Massachusetts, United States
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Spectographic metabolite-signature for identifying a subject's susceptibility to drugs||Oct 09, 2019||Application|
|Nmr-metabolite-signature for identifying cancer patients resistant to cdk4/6 inhibitors, endocrine therapy and anti-her2 therapy||Oct 09, 2019||Application|